IPSEN PHARMA SAS
502099-1732ActiveGlobal mid-size biopharma focused on oncology, rare diseases, neuroscience.
Biopharmaceutical Companyipsen.com
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2025
- Perustettu
Avainpäättäjät
Pierrick Lefranc
Executive Vice President Technical Operations
Peter Guenter
Member of the Board of Directors
Florence Meyer-Losic
Vice President and Head of Translational Sciences
David Loew
CEO
+1 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Ipsen is a global, mid-size pharmaceutical company dedicated to improving people’s lives and health outcomes by focusing on areas of high unmet medical need. With a team of over 5,000 dedicated professionals worldwide, the company accelerates its momentum to bring innovative medicines to patients. I...
ASTRAZENECA AS